# Pegasystems Inc: financial statements, quarterly

PEGA · Nasdaq · CIK 1013857 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pega.md) · [Financials](/companies/pega/financials.md) · [Filings](/companies/pega/filings.md) · [Insiders](/companies/pega/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pega/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [474 d](/filings/0001013857-26-000017.md) | [330](/filings/0001013857-25-000104.md) | [351](/filings/0001013857-25-000210.md) | [325](/filings/0001013857-25-000218.md) | [491 d](/filings/0001013857-26-000017.md) | [476](/filings/0001013857-26-000026.md) | [385](/filings/0001013857-26-000050.md) | [381](/filings/0001013857-26-000058.md) | [504 d](/filings/0001013857-26-000017.md) | [430](/filings/0001013857-26-000026.md) | [421](/filings/0001013857-26-000050.md) | [393](/filings/0001013857-26-000058.md) |
| Cost of revenue | $m | [90.6 d](/filings/0001013857-26-000017.md) | [94.7](/filings/0001013857-25-000104.md) | [96.9](/filings/0001013857-25-000210.md) | [96.7](/filings/0001013857-25-000218.md) | [102 d](/filings/0001013857-26-000017.md) | [102](/filings/0001013857-26-000026.md) | [110](/filings/0001013857-26-000050.md) | [106](/filings/0001013857-26-000058.md) | [103 d](/filings/0001013857-26-000017.md) | [107](/filings/0001013857-26-000026.md) | [108](/filings/0001013857-26-000050.md) | [104](/filings/0001013857-26-000058.md) |
| Gross profit | $m | [384 d](/filings/0001013857-26-000017.md) | [235](/filings/0001013857-25-000104.md) | [254](/filings/0001013857-25-000210.md) | [228](/filings/0001013857-25-000218.md) | [388 d](/filings/0001013857-26-000017.md) | [373](/filings/0001013857-26-000026.md) | [275](/filings/0001013857-26-000050.md) | [275](/filings/0001013857-26-000058.md) | [401 d](/filings/0001013857-26-000017.md) | [323](/filings/0001013857-26-000026.md) | [313](/filings/0001013857-26-000050.md) | [290](/filings/0001013857-26-000058.md) |
| Research and development | $m | [71.3 d](/filings/0001013857-26-000017.md) | [72.1](/filings/0001013857-25-000104.md) | [75.4](/filings/0001013857-25-000210.md) | [74.2](/filings/0001013857-25-000218.md) | [76.4 d](/filings/0001013857-26-000017.md) | [74.3](/filings/0001013857-26-000026.md) | [78.8](/filings/0001013857-26-000050.md) | [78.8](/filings/0001013857-26-000058.md) | [80.9 d](/filings/0001013857-26-000017.md) | [82.0](/filings/0001013857-26-000026.md) | [84.2](/filings/0001013857-26-000050.md) | [74.3](/filings/0001013857-26-000058.md) |
| Operating income | $m | [155 d](/filings/0001013857-26-000017.md) | [(20.4)](/filings/0001013857-25-000104.md) | [13.0](/filings/0001013857-25-000210.md) | [(11.7)](/filings/0001013857-25-000218.md) | [143 d](/filings/0001013857-26-000017.md) | [127](/filings/0001013857-26-000026.md) | [17.3](/filings/0001013857-26-000050.md) | [14.5](/filings/0001013857-26-000058.md) | [104 d](/filings/0001013857-26-000017.md) | [37.1](/filings/0001013857-26-000026.md) | [16.6](/filings/0001013857-26-000050.md) | [14.9](/filings/0001013857-26-000058.md) |
| Interest expense | $m | [1.6 d](/filings/0001013857-24-000012.md) | [1.8](/filings/0001013857-24-000085.md) | [1.7](/filings/0001013857-25-000210.md) | [1.6](/filings/0001013857-25-000218.md) | [1.8 d](/filings/0001013857-26-000017.md) | [1.0](/filings/0001013857-26-000026.md) | [0.0](/filings/0001013857-26-000050.md) | [0.1](/filings/0001013857-26-000058.md) | [0.1 d](/filings/0001013857-26-000017.md) | [0.0](/filings/0001013857-26-000026.md) | [0.0](/filings/0001013857-26-000050.md) | [0.1](/filings/0001013857-26-000058.md) |
| Income tax | $m | [12.2 d](/filings/0001013857-26-000017.md) | [(3.0)](/filings/0001013857-25-000104.md) | [8.6](/filings/0001013857-25-000210.md) | [2.8](/filings/0001013857-25-000218.md) | [35.1 d](/filings/0001013857-26-000017.md) | [40.9](/filings/0001013857-26-000026.md) | [(4.8)](/filings/0001013857-26-000050.md) | [(19.3)](/filings/0001013857-26-000058.md) | [(130) d](/filings/0001013857-26-000017.md) | [6.9](/filings/0001013857-26-000026.md) | [5.2](/filings/0001013857-26-000050.md) | [3.7](/filings/0001013857-26-000058.md) |
| Net income | $m | [143 d](/filings/0001013857-26-000017.md) | [(12.1)](/filings/0001013857-25-000218.md) | [6.6](/filings/0001013857-25-000218.md) | [(14.4)](/filings/0001013857-25-000218.md) | [119 d](/filings/0001013857-26-000017.md) | [85.4](/filings/0001013857-26-000058.md) | [30.1](/filings/0001013857-26-000058.md) | [43.4](/filings/0001013857-26-000058.md) | [235 d](/filings/0001013857-26-000017.md) | [32.8](/filings/0001013857-26-000058.md) | [13.3](/filings/0001013857-26-000058.md) | [14.1](/filings/0001013857-26-000058.md) |
| Diluted EPS | $ per share | not reported | [(0.14)](/filings/0001013857-25-000104.md) | [0.04](/filings/0001013857-25-000210.md) | [(0.08)](/filings/0001013857-25-000218.md) | not reported | [0.46](/filings/0001013857-26-000026.md) | [0.17](/filings/0001013857-26-000050.md) | [0.24](/filings/0001013857-26-000058.md) | not reported | [0.18](/filings/0001013857-26-000026.md) | [0.08](/filings/0001013857-26-000050.md) | [0.08](/filings/0001013857-26-000058.md) |
| Basic EPS | $ per share | not reported | [(0.14)](/filings/0001013857-25-000104.md) | [0.04](/filings/0001013857-25-000210.md) | [(0.08)](/filings/0001013857-25-000218.md) | not reported | [0.50](/filings/0001013857-26-000026.md) | [0.18](/filings/0001013857-26-000050.md) | [0.25](/filings/0001013857-26-000058.md) | not reported | [0.19](/filings/0001013857-26-000026.md) | [0.08](/filings/0001013857-26-000050.md) | [0.09](/filings/0001013857-26-000058.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [230](/filings/0001013857-26-000017.md) | [292](/filings/0001013857-25-000104.md) | [258](/filings/0001013857-25-000210.md) | [288](/filings/0001013857-25-000218.md) | [337](/filings/0001013857-26-000017.md) | [231](/filings/0001013857-26-000026.md) | [202](/filings/0001013857-26-000050.md) | [149](/filings/0001013857-26-000058.md) | [212](/filings/0001013857-26-000058.md) | [270](/filings/0001013857-26-000026.md) | [185](/filings/0001013857-26-000050.md) | [202](/filings/0001013857-26-000058.md) |
| Current assets | $m | [1,029](/filings/0001013857-25-000024.md) | [1,060](/filings/0001013857-24-000085.md) | [1,072](/filings/0001013857-24-000155.md) | [1,119](/filings/0001013857-24-000226.md) | [1,334](/filings/0001013857-26-000017.md) | [846](/filings/0001013857-25-000104.md) | [846](/filings/0001013857-25-000210.md) | [812](/filings/0001013857-25-000218.md) | [978](/filings/0001013857-26-000058.md) | [904](/filings/0001013857-26-000026.md) | [762](/filings/0001013857-26-000050.md) | [704](/filings/0001013857-26-000058.md) |
| Total assets | $m | [1,511](/filings/0001013857-25-000024.md) | [1,512](/filings/0001013857-24-000085.md) | [1,537](/filings/0001013857-24-000155.md) | [1,579](/filings/0001013857-24-000226.md) | [1,768](/filings/0001013857-26-000017.md) | [1,322](/filings/0001013857-25-000104.md) | [1,324](/filings/0001013857-25-000210.md) | [1,293](/filings/0001013857-25-000218.md) | [1,632](/filings/0001013857-26-000058.md) | [1,551](/filings/0001013857-26-000026.md) | [1,384](/filings/0001013857-26-000050.md) | [1,330](/filings/0001013857-26-000058.md) |
| Current liabilities | $m | [577](/filings/0001013857-25-000024.md) | [1,044](/filings/0001013857-24-000085.md) | [1,017](/filings/0001013857-24-000155.md) | [1,025](/filings/0001013857-24-000226.md) | [1,086](/filings/0001013857-26-000017.md) | [609](/filings/0001013857-25-000104.md) | [600](/filings/0001013857-25-000210.md) | [597](/filings/0001013857-25-000218.md) | [738](/filings/0001013857-26-000058.md) | [743](/filings/0001013857-26-000026.md) | [719](/filings/0001013857-26-000050.md) | [679](/filings/0001013857-26-000058.md) |
| Total liabilities | $m | [1,157](/filings/0001013857-25-000024.md) | [1,122](/filings/0001013857-24-000085.md) | [1,101](/filings/0001013857-24-000155.md) | [1,106](/filings/0001013857-24-000226.md) | [1,183](/filings/0001013857-26-000017.md) | [711](/filings/0001013857-25-000104.md) | [700](/filings/0001013857-25-000210.md) | [696](/filings/0001013857-25-000218.md) | [844](/filings/0001013857-26-000058.md) | [845](/filings/0001013857-26-000026.md) | [824](/filings/0001013857-26-000050.md) | [781](/filings/0001013857-26-000058.md) |
| Shareholders' equity | $m | [354](/filings/0001013857-26-000017.md) | [390](/filings/0001013857-25-000218.md) | [435](/filings/0001013857-25-000218.md) | [473](/filings/0001013857-25-000218.md) | [585](/filings/0001013857-26-000058.md) | [611](/filings/0001013857-26-000058.md) | [625](/filings/0001013857-26-000058.md) | [597](/filings/0001013857-26-000058.md) | [787](/filings/0001013857-26-000058.md) | [706](/filings/0001013857-26-000058.md) | [560](/filings/0001013857-26-000058.md) | [549](/filings/0001013857-26-000058.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [79.9 d](/filings/0001013857-26-000017.md) | [180](/filings/0001013857-25-000104.md) | [40.1 d](/filings/0001013857-25-000210.md) | [30.5 d](/filings/0001013857-25-000218.md) | [95.2 d](/filings/0001013857-26-000017.md) | [204](/filings/0001013857-26-000026.md) | [86.3 d](/filings/0001013857-26-000050.md) | [56.3 d](/filings/0001013857-26-000058.md) | [158 d](/filings/0001013857-26-000017.md) | [212](/filings/0001013857-26-000026.md) | [86.0 d](/filings/0001013857-26-000050.md) | [6.1 d](/filings/0001013857-26-000058.md) |
| Capital expenditure | $m | [2.5 d](/filings/0001013857-26-000017.md) | [0.6](/filings/0001013857-25-000104.md) | [1.3 d](/filings/0001013857-25-000210.md) | [3.1 d](/filings/0001013857-25-000218.md) | [2.8 d](/filings/0001013857-26-000017.md) | [1.9](/filings/0001013857-26-000026.md) | [2.1 d](/filings/0001013857-26-000050.md) | [4.5 d](/filings/0001013857-26-000058.md) | [6.0 d](/filings/0001013857-26-000017.md) | [5.7](/filings/0001013857-26-000026.md) | [4.2 d](/filings/0001013857-26-000050.md) | [4.5 d](/filings/0001013857-26-000058.md) |
| Dividends paid | $m | [2.5 d](/filings/0001013857-26-000017.md) | [2.5](/filings/0001013857-25-000104.md) | [2.6 d](/filings/0001013857-25-000210.md) | [2.6 d](/filings/0001013857-25-000218.md) | [2.6 d](/filings/0001013857-26-000017.md) | [2.6](/filings/0001013857-26-000026.md) | [2.6 d](/filings/0001013857-26-000050.md) | [5.2 d](/filings/0001013857-26-000058.md) | [5.1 d](/filings/0001013857-26-000017.md) | [5.1](/filings/0001013857-26-000026.md) | [5.1 d](/filings/0001013857-26-000050.md) | [4.9 d](/filings/0001013857-26-000058.md) |
| Share repurchases | $m | [0.0 d](/filings/0001013857-26-000017.md) | [0.0](/filings/0001013857-25-000104.md) | [0.0 d](/filings/0001013857-25-000210.md) | [11.2 d](/filings/0001013857-25-000218.md) | [56.8 d](/filings/0001013857-26-000017.md) | [117](/filings/0001013857-26-000026.md) | [134 d](/filings/0001013857-26-000050.md) | [143 d](/filings/0001013857-26-000058.md) | [105 d](/filings/0001013857-26-000017.md) | [167](/filings/0001013857-26-000026.md) | [200 d](/filings/0001013857-26-000050.md) | [65.0 d](/filings/0001013857-26-000058.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [82.6](/filings/0001013857-24-000085.md) | [83.0](/filings/0001013857-24-000155.md) | [83.3](/filings/0001013857-24-000226.md) | [84.3](/filings/0001013857-25-000104.md) | [177](/filings/0001013857-25-000210.md) | [171](/filings/0001013857-25-000218.md) | [189](/filings/0001013857-26-000026.md) | [182](/filings/0001013857-26-000050.md) | [184](/filings/0001013857-26-000058.md) | [179](/filings/0001013857-26-000026.md) | [172](/filings/0001013857-26-000050.md) | [169](/filings/0001013857-26-000058.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 163,663,545 at 2026-10-12, from the cover of the [10-Q filed 2026-10-20](/filings/0001013857-26-000058.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.